Free Trial

Docket growing rapidly, Pfizer 7-parter,...>

PIPELINE
PIPELINE: Docket growing rapidly, Pfizer 7-parter, Unilever, Duke Realty
Date $MM Issuer/Rating/Desc/Maturity/Yld/Leads; Priced *; Launch #:
09/04 $3B EIB 3Y WNG MS+1a
09/04 $Benchmark MUFG 5Y fix/FRN, 10Y +105a  
09/04 $Benchmark Pfizer 7-part: 3- and 5Y fix/FRN, 10Y +80a, 20Y +105a, 30Y
+120a
09/04 $Benchmark Unilever capital 3Y +55a, 5Y +70a, 10Y +85a
09/04 $Benchmark Duke Realty Ltd 10Y 
- 
Potential for massive jump in issuance on week, estimates running over $50B
(>$120B for September) w/Cigna planning over $22B jumbo issuance to help finance
acquisition of Express Scripts. Potential additions to pipeline in coming weeks:
* Bank of China (Hong Kong) Ltd.
* Home Depot

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.